We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+35.27%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$151M
AUM Growth
+$23.7M
Cap. Flow
-$10.9M
Cap. Flow %
-7.21%
Top 10 Hldgs %
49.48%
Holding
78
New
25
Increased
14
Reduced
22
Closed
12

Top Buys

Rank Stock Value
1
AVAV icon
AeroVironment
AVAV
+$3.78M
2
AXGN icon
Axogen
AXGN
+$2.78M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$2.41M
4
DRRX
DURECT Corp
DRRX
+$2.36M
5
CUTR
Cutera, Inc.
CUTR
+$1.95M

Top Sells

Rank Stock Value
1
BEAT
BioTelemetry, Inc.
BEAT
+$7.34M
2
MSTR icon
Strategy Inc
MSTR
+$4.07M
3
RPRX
Repros Therapeutics Inc.
RPRX
+$3.69M
4
UI icon
Ubiquiti
UI
+$3.4M
5
COA
COASTAL CONTACTS INC COMMON SHARES (CANADA)
COA
+$2.89M

Sector Composition

Rank Sector Weight
1 Healthcare 50.2%
2 Technology 28.6%
3 Communication Services 5.65%
4 Industrials 3.63%
5 Materials 3.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASPS icon
26
Altisource Portfolio Solutions
ASPS
$63.7M
$1.89M 1.25%
1,688
-1,487
-47% -$1.44M
VSTM icon
27
Verastem
VSTM
$668M
$1.84M 1.22%
12,308
-6,279
-34% -$1.1M
ARWR icon
28
Arrowhead Research
ARWR
$12.5B
$1.68M 1.11%
+294,583
New +$1.13M
SQNS
29
Sequans Communications SA
SQNS
$44.3M
$1.62M 1.07%
6,604
-509
-7% -$101K
NKTR icon
30
Nektar Therapeutics
NKTR
$2.55B
$1.43M 0.95%
+9,140
New +$1.69M
NUWE icon
31
Nuwellis
NUWE
$3.14M
– –
0
– –
ENVI
32
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
$1.38M 0.91%
439,951
+36,423
+9% +$97.8K
SMSI icon
33
Smith Micro Software
SMSI
$16.5M
$1.36M 0.9%
9,418
-8,233
-47% -$1.37M
META icon
34
Meta Platforms (Facebook)
META
$1.45T
$1.2M 0.79%
+23,900
New +$889K
GCVRZ
35
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$1.16M 0.77%
+574,398
New +$1.09M
FLNA
36
Filana Therapeutics
FLNA
$44.6M
$1.13M 0.75%
+59,402
New +$1.04M
STRM
37
DELISTED
Streamline Health Solutions
STRM
$1.1M 0.73%
9,647
+3,994
+71% +$437K
RGDX
38
DELISTED
RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
$1.08M 0.72%
+487,805
New +$985K
ICAD
39
DELISTED
iCAD Inc
ICAD
$1.03M 0.68%
196,010
-32,881
-14% -$190K
LMNR icon
40
Limoneira
LMNR
$246M
$868K 0.57%
33,792
+10,163
+43% +$228K
HNGR
41
DELISTED
Hanger Inc.
HNGR
$803K 0.53%
+23,800
New +$791K
UPI
42
DELISTED
UROPLASTY INC-NEW
UPI
$757K 0.5%
+228,700
New +$639K
ZGNX
43
DELISTED
Zogenix, Inc.
ZGNX
$753K 0.5%
+50,750
New +$681K
CPRX
44
DELISTED
Catalyst Pharmaceutical
CPRX
$732K 0.48%
239,760
-270,240
-53% -$455K
EXAC
45
DELISTED
Exactech Inc
EXAC
$679K 0.45%
+33,700
New +$675K
ASMB icon
46
Assembly Biosciences
ASMB
$709M
$637K 0.42%
3,681
-6,038
-62% -$925K
LSTA icon
47
Lisata Therapeutics
LSTA
$16.4M
$607K 0.4%
+474
New +$526K
PSIX
48
Power Solutions International
PSIX
$871M
$591K 0.39%
+10,000
New +$487K
TSEM icon
49
Tower Semiconductor
TSEM
$24.8B
$563K 0.37%
115,559
+49,080
+74% +$233K
TIVO
50
DELISTED
Tivo Inc
TIVO
$479K 0.32%
+25,000
New +$500K
1
2
3 4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Sophrosyne Capital held 78 positions worth $151M, up 19% from $128M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sophrosyne Capital withdrew a net $10.9M in Q3 2013, closing 12 positions and reducing 22 holdings. Its most notable exit was COASTAL CONTACTS INC COMMON SHARES (CANADA), an estimated $2.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 46% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Sophrosyne Capital opened a new position in AeroVironment worth $3.9M.

  • Sophrosyne Capital's largest Q3 2013 buy was AeroVironment: 169,426 shares worth $3.9M.
  • Sophrosyne Capital added most to Sarepta Therapeutics in Q3 2013, an estimated $2.41M increase.
  • Sophrosyne Capital's biggest Q3 2013 reduction was BioTelemetry, Inc., cutting an estimated $7.34M.
  • Sophrosyne Capital fully exited COASTAL CONTACTS INC COMMON SHARES (CANADA) in Q3 2013, selling an estimated $2.89M.
  • Sophrosyne Capital's ten largest holdings make up 49% of its $151M portfolio in Q3 2013.
  • Sophrosyne Capital opened 25 new positions and closed 12 in Q3 2013.
  • Sophrosyne Capital's portfolio value rose 19% quarter-over-quarter to $151M.

Based on Sophrosyne Capital's 13F filing for Q3 2013, filed 14 Nov 2013.